Evaluation of Novel Inhibitors of Tryptophan Dioxygenases for Enzyme and Species Selectivity Using Engineered Tumour Cell Lines Expressing Either Murine or Human IDO1 or TDO2

Indoleamine 2, 3-dioxygenase 1 (IDO1) is commonly expressed by cancers as a mechanism for evading the immune system. Preclinical and clinical studies have indicated the potential of combining IDO1 inhibitors with immune therapies for the treatment of cancer, strengthening an interest in the discover...

Descripción completa

Detalles Bibliográficos
Autores principales: Tijono, Sofian M, Palmer, Brian D., Tomek, Petr, Flanagan, Jack U., Henare, Kimiora, Gamage, Swarna, Braun, Lukas, Ching, Lai-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501369/
https://www.ncbi.nlm.nih.gov/pubmed/36145311
http://dx.doi.org/10.3390/ph15091090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501369/
https://www.ncbi.nlm.nih.gov/pubmed/36145311
http://dx.doi.org/10.3390/ph15091090

Ejemplares similares